share_log

Morgan Stanley Maintains Equal-Weight on Anterix, Lowers Price Target to $41

Benzinga ·  Aug 1, 2023 22:39

Morgan Stanley analyst Nigel Dally maintains Anterix (NASDAQ:ATEX) with a Equal-Weight and lowers the price target from $42 to $41.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment